Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

138 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Completed

A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

NCT03656718

Conditions
Neoplasms, Neoplasms by Site
Locations
  • Winship Cancer Institute. Atlanta, Georgia, United States
  • Local Institution - 0024 Rockville, Maryland, United States
  • Local Institution - 0020 Detroit, Michigan, United States
  • Local Institution - 0001 Charlotte, North Carolina, United States
View all 36 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

NCT03150862

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Center For Neurosciences Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • University of California At San Francisco San Francisco, California, United States
  • Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
View all 22 locations
View Trial Details
Completed

Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)

NCT02112656

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • Toronto General Hospital Toronto, Ontario, Canada
  • Mengchao Hepatobiliary Hospital of Fujian Medicatl University Fuzhou, Fujian, China
  • Xijing Hospital Xi'an, Shaanxi, China
View all 61 locations
View Trial Details

Related conditions